1. Home
  2. GBIO vs MDV Comparison

GBIO vs MDV Comparison

Compare GBIO & MDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • MDV
  • Stock Information
  • Founded
  • GBIO 2016
  • MDV 2015
  • Country
  • GBIO United States
  • MDV United States
  • Employees
  • GBIO N/A
  • MDV N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • MDV Transportation Services
  • Sector
  • GBIO Health Care
  • MDV Consumer Discretionary
  • Exchange
  • GBIO Nasdaq
  • MDV Nasdaq
  • Market Cap
  • GBIO 165.5M
  • MDV 150.0M
  • IPO Year
  • GBIO 2020
  • MDV 2022
  • Fundamental
  • Price
  • GBIO $1.67
  • MDV $15.93
  • Analyst Decision
  • GBIO Strong Buy
  • MDV Strong Buy
  • Analyst Count
  • GBIO 2
  • MDV 1
  • Target Price
  • GBIO $7.50
  • MDV $18.00
  • AVG Volume (30 Days)
  • GBIO 137.7K
  • MDV 39.0K
  • Earning Date
  • GBIO 11-06-2024
  • MDV 11-06-2024
  • Dividend Yield
  • GBIO N/A
  • MDV 7.18%
  • EPS Growth
  • GBIO N/A
  • MDV N/A
  • EPS
  • GBIO N/A
  • MDV N/A
  • Revenue
  • GBIO $18,582,000.00
  • MDV $47,416,592.00
  • Revenue This Year
  • GBIO $99.36
  • MDV N/A
  • Revenue Next Year
  • GBIO N/A
  • MDV $1.91
  • P/E Ratio
  • GBIO N/A
  • MDV N/A
  • Revenue Growth
  • GBIO 514.08
  • MDV N/A
  • 52 Week Low
  • GBIO $1.06
  • MDV $13.27
  • 52 Week High
  • GBIO $4.65
  • MDV $18.11
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 32.17
  • MDV 39.01
  • Support Level
  • GBIO $2.14
  • MDV $15.76
  • Resistance Level
  • GBIO $2.57
  • MDV $17.71
  • Average True Range (ATR)
  • GBIO 0.19
  • MDV 0.55
  • MACD
  • GBIO -0.04
  • MDV -0.14
  • Stochastic Oscillator
  • GBIO 1.23
  • MDV 12.15

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About MDV Modiv Industrial Inc. Class C

Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.

Share on Social Networks: